Age-related defects in maintaining proteostasis are thought to be major contributing factors to a variety of degenerative diseases, including Alzheimer's and Parkinson's, as well as aging itself. A major contributing factor to these pathologies is the inability of the proteasome to keep up with the accumulation of mis-folded proteins, which eventually accumulate to levels sufficient to form cytotoxic amyloids. One therapeutic strategy to combat this process is to develop agonists of the proteasome-mediated turnover of mis-folded proteins, but progress has been frustratingly slow and no bona fide small molecule agonists are currently available. This R21 proposal asks for support to apply both novel chemistry and an innovative screening assay to solve this problem. If successful, this project will set the stage for a chemical biology-based exploration of the utility of proteasome stimulation in combating a variety of protein folding diseases for which good treatment options are not currently available.
The accumulation of mis-folded proteins results in the formation of cytotoxic, amyloidogenic aggregates, which are thought to contribute to a variety of diseases, including Alzheimer's and Parkinson's. There is considerable interest in exploring the idea that stimulation of proteasome activity would counter this build-up, but no potent small molecule proteasome agonists are available. This R21 proposal seeks funding to support a novel screen by which hundreds of thousands of conformationally restricted oligomers will be assayed for proteasome binding as well as bona fide stimulation of the turnover of physiologically relevant, mis-folded proteins.
| Erharuyi, Osayemwenre; Simanski, Scott; McEnaney, Patrick J et al. (2018) Screening one bead one compound libraries against serum using a flow cytometer: Determination of the minimum antibody concentration required for ligand discovery. Bioorg Med Chem Lett 28:2773-2778 |
| Shu, Keitou; Kodadek, Thomas (2018) Solid-Phase Synthesis of ?-Hydroxy Ketones Via DNA-Compatible Organocatalytic Aldol Reactions. ACS Comb Sci 20:277-281 |
